ES2089136T3 - Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas. - Google Patents

Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas.

Info

Publication number
ES2089136T3
ES2089136T3 ES91306069T ES91306069T ES2089136T3 ES 2089136 T3 ES2089136 T3 ES 2089136T3 ES 91306069 T ES91306069 T ES 91306069T ES 91306069 T ES91306069 T ES 91306069T ES 2089136 T3 ES2089136 T3 ES 2089136T3
Authority
ES
Spain
Prior art keywords
treatment
inflammatory diseases
prostaglandinas
ceto
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91306069T
Other languages
English (en)
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R Tech Ueno Ltd
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ES2089136T3 publication Critical patent/ES2089136T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UTILIZACION DE UN COMPUESTO DE 15-CETOPROSTAGLANDINA PARA FABRICAR UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS.
ES91306069T 1990-07-10 1991-07-03 Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas. Expired - Lifetime ES2089136T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18496390 1990-07-10

Publications (1)

Publication Number Publication Date
ES2089136T3 true ES2089136T3 (es) 1996-10-01

Family

ID=16162415

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91306069T Expired - Lifetime ES2089136T3 (es) 1990-07-10 1991-07-03 Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas.

Country Status (10)

Country Link
US (1) US5346921A (es)
EP (1) EP0467564B1 (es)
JP (1) JP2562239B2 (es)
KR (1) KR100195430B1 (es)
AT (1) ATE137116T1 (es)
CA (1) CA2046069C (es)
DE (1) DE69118978T2 (es)
DK (1) DK0467564T3 (es)
ES (1) ES2089136T3 (es)
GR (1) GR3019760T3 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508302A (en) * 1994-09-28 1996-04-16 American Home Products Corporation Phospholipase A2 inhibitors
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
DK0857718T3 (da) * 1996-06-10 2002-12-16 Sucampo Ag Endothelinantagonist
AU739343B2 (en) * 1997-11-28 2001-10-11 Sucampo Ag Endothelin antagonist
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
AR026046A1 (es) 1999-10-15 2002-12-26 R Tech Ueno Ltd NUEVA COMPOSICIoN Y MÉTODO PARA ESTABILIZAR LA MISMA
ATE387204T1 (de) * 2001-05-18 2008-03-15 Sucampo Ag Zusammensetzung mit induzierendem kathartischen effekt
MXPA04001604A (es) * 2001-08-23 2004-07-08 Sucampo Ag Metodo y composicion para tratamiento de hipertension ocular y glaucoma.
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
KR20160120809A (ko) * 2005-03-04 2016-10-18 수캄포 아게 말초 혈관 질환 치료를 위한 방법 및 조성물
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
US20070037193A1 (en) * 2005-08-12 2007-02-15 Rong-Hwa Lin Modulation of peroxisome proliferator-activated receptors
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
EP2730283A4 (en) * 2011-06-21 2015-06-03 R Tech Ueno Ltd PHARMACEUTICAL COMPOSITION FOR INFLAMMATORY DISEASES, ALLERGIC DISEASES AND AUTOIMMUNE DISEASES
KR102578588B1 (ko) * 2021-07-22 2023-09-14 정찬희 자석이 구비된 도어 잠금장치

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2321876A1 (fr) * 1975-08-29 1977-03-25 Roussel Uclaf Nouveaux derives cyclopentaniques, leur procede de preparation et leur application comme medicaments
US4097603A (en) * 1977-09-06 1978-06-27 The Upjohn Company Gastric cytoprotection with non-antisecretory doses of prostaglandins
NL8105635A (nl) * 1981-12-15 1983-07-01 Univ Erasmus Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
JPS59134746A (ja) * 1982-11-05 1984-08-02 ザ，プロクタ−，エンド，ギヤンブル，カンパニ− 新規プロスタグランジン類似体
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
US4612330A (en) * 1985-02-04 1986-09-16 Eli Lilly And Company Antiinflammatory method
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
EP0292177B1 (en) * 1987-05-15 1992-03-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Fervescence composition
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
GB2210556B (en) * 1987-10-02 1991-07-17 Ueno Seiyaku Oyo Kenkyujo Kk The use of 15-keto-16-halo-prostaglandins in cathartic compositions
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
EP0343904B1 (en) * 1988-05-23 1993-04-28 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Hypersphyxia causing composition
JP2515442B2 (ja) * 1990-05-01 1996-07-10 株式会社上野製薬応用研究所 膵臓疾患処置剤

Also Published As

Publication number Publication date
CA2046069C (en) 2002-04-09
EP0467564A3 (en) 1992-07-08
DE69118978T2 (de) 1996-11-14
EP0467564B1 (en) 1996-04-24
DE69118978D1 (de) 1996-05-30
EP0467564A2 (en) 1992-01-22
KR100195430B1 (ko) 1999-06-15
ATE137116T1 (de) 1996-05-15
JP2562239B2 (ja) 1996-12-11
DK0467564T3 (da) 1996-05-13
CA2046069A1 (en) 1992-01-11
JPH0532551A (ja) 1993-02-09
KR920002151A (ko) 1992-02-28
US5346921A (en) 1994-09-13
GR3019760T3 (en) 1996-07-31

Similar Documents

Publication Publication Date Title
DK0453127T3 (da) Behandling af katarakt med 15-keto-prostaglandinforbindelser
ES2093361T3 (es) Tratamiento de enfermedades neurodegenerativas.
ATE69376T1 (de) Haarwuchsmittel.
ES2089136T3 (es) Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas.
ES2093774T3 (es) Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
FI933902A7 (fi) Substituoidut sykloheksaanijohdannaiset sairauksien hoitamiseksi
DK0424156T3 (da) Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
FI925544A7 (fi) Bentsoehappojohdannaisia leukotrieeniin liittyvien sairauksien hoitami seen
KR930702990A (ko) 섬유성 질병 치료제로서의 프로스타사이클린- 및 카르바사이클린 유도체
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ES2098325T3 (es) Tratamiento de cataratas con compuestos de prostaciclina.
FI925546A7 (fi) Amidiliittyneitä pyridyylihappojohdannaisia leukotrieeniin liittyvien sairauksien hoitamiseksi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 467564

Country of ref document: ES

FG2A Definitive protection

Ref document number: 467564

Country of ref document: ES